[EN] DIHYDROQUINAZOLINONE ANALOGUES AS BRD4 INHIBITORS<br/>[FR] ANALOGUES DE LA DIHYDROQUINAZOLINONE UTILISÉS COMME INHIBITEURS DE LA BRD4
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2014154762A1
公开(公告)日:2014-10-02
The present invention encompasses compounds of general formula (I) wherein the groups R1 to R4 and A1 to A5 have the meanings given in the claims and in the specification. The compounds of the invention are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation pharmaceutical preparations containing such compounds and their uses as a medicament.
本发明涵盖了通式(I)中的化合物,其中基团R1至R4和A1至A5的含义如权利要求和说明书中所述。本发明的化合物适用于治疗由细胞过度或异常增殖所特征化的疾病,包括含有这些化合物的药物制剂以及它们作为药物的用途。